Skip to main content
Top
Published in: Journal of Endocrinological Investigation 4/2017

01-04-2017 | Original Article

Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity

Authors: P. Di Bonito, L. Pacifico, C. Chiesa, G. Valerio, E. Miraglia del Giudice, C. Maffeis, A. Morandi, C. Invitti, M. R. Licenziati, S. Loche, G. Tornese, F. Franco, M. Manco, M. G. Baroni, for the “CARdiometabolic risk factors in overweight and obese children in ITALY” (CARITALY) Study Group

Published in: Journal of Endocrinological Investigation | Issue 4/2017

Login to get access

Abstract

Objective

To investigate in a large sample of overweight/obese (OW/OB) children and adolescents the prevalence of prediabetic phenotypes such as impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), and to assess their association with cardiometabolic risk (CMR) factors including hepatic steatosis (HS).

Methods

Population data were obtained from the CARdiometabolic risk factors in children and adolescents in ITALY study. Between 2003 and 2013, 3088 youths (972 children and 2116 adolescents) received oral glucose tolerance test (OGTT) and were included in the study. In 798 individuals, abdominal ultrasound for identification of HS was available.

Results

The prevalence of IFG (3.2 vs. 3.3%) and IGT (4.6 vs. 5.0%) was similar between children and adolescents. Children with isolated IGT had a 2–11 fold increased risk of high LDL-C, non-HDL-C, Tg/HDL-C ratio, and low insulin sensitivity, when compared to those with normal glucose tolerance (NGT). No significant association of IFG with any CMR factor was found in children. Among adolescents, IGT subjects, and to a lesser extent those with IFG, showed a worse CMR profile compared to NGT subgroup. In the overall sample, IGT phenotype showed a twofold increased risk of HS compared to NGT subgroup.

Conclusions

Our study shows an unexpected similar prevalence of IFG and IGT between children and adolescents with overweight/obesity. The IGT phenotype was associated with a worse CMR profile in both children and adolescents. Phenotyping prediabetes conditions by OGTT should be done as part of prediction and prevention of cardiometabolic diseases in OW/OB youth since early childhood.
Appendix
Available only for authorised users
Literature
2.
go back to reference Shashaj B, Bedogni G, Graziani MP et al (2014) Origin of cardiovascular risk in overweight preschool children: a cohort study of cardiometabolic risk factors at the onset of obesity. JAMA Pediatr 168(10):917–924CrossRefPubMed Shashaj B, Bedogni G, Graziani MP et al (2014) Origin of cardiovascular risk in overweight preschool children: a cohort study of cardiometabolic risk factors at the onset of obesity. JAMA Pediatr 168(10):917–924CrossRefPubMed
3.
go back to reference Giannini C, Caprio S (2013) Progression of β-cell dysfunction in obese youth. Curr Diab Rep 13(1):89–95CrossRefPubMed Giannini C, Caprio S (2013) Progression of β-cell dysfunction in obese youth. Curr Diab Rep 13(1):89–95CrossRefPubMed
4.
go back to reference Meyer C, Pimenta W, Woerle HJ et al (2006) Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29(8):1909–1914CrossRefPubMed Meyer C, Pimenta W, Woerle HJ et al (2006) Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care 29(8):1909–1914CrossRefPubMed
5.
go back to reference Nathan DM, Davidson MB, DeFronzo RA et al (2007) American Diabetes Association. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30(3):753–759CrossRefPubMed Nathan DM, Davidson MB, DeFronzo RA et al (2007) American Diabetes Association. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30(3):753–759CrossRefPubMed
6.
go back to reference American Diabetes Association (2016) Classification and diagnosis of diabetes. Diabetes Care 39(Suppl 1):S13–S22 American Diabetes Association (2016) Classification and diagnosis of diabetes. Diabetes Care 39(Suppl 1):S13–S22
7.
go back to reference Morrison KM, Xu L, Tarnopolsky M, Yusuf Z, Atkinson SA, Yusuf S (2012) Screening for dysglycemia in overweight youth presenting for weight management. Diabetes Care 35(4):711–716CrossRefPubMedPubMedCentral Morrison KM, Xu L, Tarnopolsky M, Yusuf Z, Atkinson SA, Yusuf S (2012) Screening for dysglycemia in overweight youth presenting for weight management. Diabetes Care 35(4):711–716CrossRefPubMedPubMedCentral
8.
go back to reference Hagman E, Reinehr T, Kowalski J, Ekbom A, Marcus C, Holl RW (2014) Impaired fasting glucose prevalence in two nationwide cohorts of obese children and adolescents. Int J Obes 38(1):40–45CrossRef Hagman E, Reinehr T, Kowalski J, Ekbom A, Marcus C, Holl RW (2014) Impaired fasting glucose prevalence in two nationwide cohorts of obese children and adolescents. Int J Obes 38(1):40–45CrossRef
9.
go back to reference Vukovic R, Mitrovic K, Milenkovic T, Todorovic S, Zdravkovic D (2012) Type 2 diabetes mellitus and impaired glucose regulation in overweight and obese children and adolescents living in Serbia. Int J Obes 36(11):1479–1481CrossRef Vukovic R, Mitrovic K, Milenkovic T, Todorovic S, Zdravkovic D (2012) Type 2 diabetes mellitus and impaired glucose regulation in overweight and obese children and adolescents living in Serbia. Int J Obes 36(11):1479–1481CrossRef
10.
go back to reference Ek AE, Rössner SM, Hagman E, Marcus C (2015) High prevalence of prediabetes in a Swedish cohort of severely obese children. Pediatr Diabetes 16(2):117–128CrossRefPubMed Ek AE, Rössner SM, Hagman E, Marcus C (2015) High prevalence of prediabetes in a Swedish cohort of severely obese children. Pediatr Diabetes 16(2):117–128CrossRefPubMed
11.
go back to reference Hagman E, Arani PI, Fischer M et al (2014) Blood sugar levels are higher in obese young children in Sweden than in Poland. Acta Paediatr 103(11):1174–1178CrossRefPubMed Hagman E, Arani PI, Fischer M et al (2014) Blood sugar levels are higher in obese young children in Sweden than in Poland. Acta Paediatr 103(11):1174–1178CrossRefPubMed
12.
go back to reference Sinha R, Fisch G, Teague B et al (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346(11):802–810CrossRefPubMed Sinha R, Fisch G, Teague B et al (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346(11):802–810CrossRefPubMed
13.
go back to reference Tester J, Sharma S, Jasik CB, Mietus-Snyder M, Tinajero-Deck L (2013) Gender differences in prediabetes and insulin resistance among 1356 obese children in Northern California. Diabetes Metab Syndr 7(3):161–165CrossRefPubMed Tester J, Sharma S, Jasik CB, Mietus-Snyder M, Tinajero-Deck L (2013) Gender differences in prediabetes and insulin resistance among 1356 obese children in Northern California. Diabetes Metab Syndr 7(3):161–165CrossRefPubMed
14.
go back to reference Shalitin S, Abrahami M, Lilos P, Phillip M (2005) Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel. Int J Obes 29(6):571–578CrossRef Shalitin S, Abrahami M, Lilos P, Phillip M (2005) Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel. Int J Obes 29(6):571–578CrossRef
15.
go back to reference Brufani C, Ciampalini P, Grossi A et al (2010) Glucose tolerance status in 510 children and adolescents attending an obesity clinic in Central Italy. Pediatr Diabetes 11(1):47–54CrossRefPubMed Brufani C, Ciampalini P, Grossi A et al (2010) Glucose tolerance status in 510 children and adolescents attending an obesity clinic in Central Italy. Pediatr Diabetes 11(1):47–54CrossRefPubMed
16.
go back to reference Brufani C, Fintini D, Ciampalini P et al (2011) Pre-diabetes in Italian obese children and youngsters. J Endocrinol Invest 34(9):e275–e280PubMed Brufani C, Fintini D, Ciampalini P et al (2011) Pre-diabetes in Italian obese children and youngsters. J Endocrinol Invest 34(9):e275–e280PubMed
17.
go back to reference Invitti C, Guzzaloni G, Gilardini L, Morabito F, Viberti G (2003) Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care 26(1):118–124CrossRefPubMed Invitti C, Guzzaloni G, Gilardini L, Morabito F, Viberti G (2003) Prevalence and concomitants of glucose intolerance in European obese children and adolescents. Diabetes Care 26(1):118–124CrossRefPubMed
18.
go back to reference Grandone A, Amato A, Luongo C, Santoro N, Perrone L, Miraglia Del Giudice E (2008) High-normal fasting glucose levels are associated with increased prevalence of impaired glucose tolerance in obese children. J Endocrinol Invest 31(12):1098–1102CrossRefPubMed Grandone A, Amato A, Luongo C, Santoro N, Perrone L, Miraglia Del Giudice E (2008) High-normal fasting glucose levels are associated with increased prevalence of impaired glucose tolerance in obese children. J Endocrinol Invest 31(12):1098–1102CrossRefPubMed
19.
go back to reference Cali AM, De Oliveira AM, Kim H et al (2009) Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? Hepatology 49(6):1896–1903CrossRefPubMedPubMedCentral Cali AM, De Oliveira AM, Kim H et al (2009) Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link? Hepatology 49(6):1896–1903CrossRefPubMedPubMedCentral
20.
go back to reference D’Adamo E, Cali AM, Weiss R et al (2010) Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 33(8):1817–1822CrossRefPubMedPubMedCentral D’Adamo E, Cali AM, Weiss R et al (2010) Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 33(8):1817–1822CrossRefPubMedPubMedCentral
21.
go back to reference Di Bonito P, Valerio G, Grugni G et al (2015) Comparison of non-HDL-cholesterol versus triglycerides-to-HDL-cholesterol ratio in relation to cardiometabolic risk factors and preclinical organ damage in overweight/obese children: the CARITALY study. Nutr Metab Cardiovasc Dis 25(5):489–494CrossRefPubMed Di Bonito P, Valerio G, Grugni G et al (2015) Comparison of non-HDL-cholesterol versus triglycerides-to-HDL-cholesterol ratio in relation to cardiometabolic risk factors and preclinical organ damage in overweight/obese children: the CARITALY study. Nutr Metab Cardiovasc Dis 25(5):489–494CrossRefPubMed
22.
go back to reference Canadian Paediatric Society (2003) Age limits and adolescents. Paediatr Child Health 8(9):577CrossRef Canadian Paediatric Society (2003) Age limits and adolescents. Paediatr Child Health 8(9):577CrossRef
23.
go back to reference Cole TJ, Lobstein T (2012) Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes 7(4):284–294CrossRefPubMed Cole TJ, Lobstein T (2012) Extended international (IOTF) body mass index cut-offs for thinness, overweight and obesity. Pediatr Obes 7(4):284–294CrossRefPubMed
24.
go back to reference Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute (2011) Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128(Suppl. 5):S213–S256CrossRefPubMedCentral Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, National Heart, Lung, and Blood Institute (2011) Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 128(Suppl. 5):S213–S256CrossRefPubMedCentral
25.
go back to reference Shashaj B, Luciano R, Contoli B et al (2016) Reference ranges of HOMA-IR in normal-weight and obese young Caucasians. Acta Diabetol 53(2):251–260CrossRefPubMed Shashaj B, Luciano R, Contoli B et al (2016) Reference ranges of HOMA-IR in normal-weight and obese young Caucasians. Acta Diabetol 53(2):251–260CrossRefPubMed
26.
go back to reference Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S (2005) Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 28(4):902–909CrossRefPubMed Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S (2005) Predictors of changes in glucose tolerance status in obese youth. Diabetes Care 28(4):902–909CrossRefPubMed
27.
go back to reference Körner A, Wiegand S, Hungele A et al (2013) Longitudinal multicenter analysis on the course of glucose metabolism in obese children. Int J Obes 37(7):931–936CrossRef Körner A, Wiegand S, Hungele A et al (2013) Longitudinal multicenter analysis on the course of glucose metabolism in obese children. Int J Obes 37(7):931–936CrossRef
28.
go back to reference Kleber M, Lass N, Papcke S, Wabitsch M, Reinehr T (2010) One-year follow-up of untreated obese white children and adolescents with impaired glucose tolerance: high conversion rate to normal glucose tolerance. Diabet Med 27(5):516–521CrossRefPubMed Kleber M, Lass N, Papcke S, Wabitsch M, Reinehr T (2010) One-year follow-up of untreated obese white children and adolescents with impaired glucose tolerance: high conversion rate to normal glucose tolerance. Diabet Med 27(5):516–521CrossRefPubMed
29.
go back to reference Kleber M, deSousa G, Papcke S, Wabitsch M, Reinehr T (2011) Impaired glucose tolerance in obese white children and adolescents: three to five year follow-up in untreated patients. Exp Clin Endocrinol Diabetes 119(3):172–176CrossRefPubMed Kleber M, deSousa G, Papcke S, Wabitsch M, Reinehr T (2011) Impaired glucose tolerance in obese white children and adolescents: three to five year follow-up in untreated patients. Exp Clin Endocrinol Diabetes 119(3):172–176CrossRefPubMed
30.
go back to reference Festa A, D’Agostino R Jr, Hanley AJ, Karter AJ, Saad MF, Haffner SM (2004) Differences in insulin resistance in nondiabetic individuals with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 53(6):1549–1555CrossRefPubMed Festa A, D’Agostino R Jr, Hanley AJ, Karter AJ, Saad MF, Haffner SM (2004) Differences in insulin resistance in nondiabetic individuals with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 53(6):1549–1555CrossRefPubMed
31.
go back to reference Lorenzo C, Hartnett S, Hanley AJ et al (2013) Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study. J Clin Endocrinol Metab 98(4):1622–1630CrossRefPubMedPubMedCentral Lorenzo C, Hartnett S, Hanley AJ et al (2013) Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study. J Clin Endocrinol Metab 98(4):1622–1630CrossRefPubMedPubMedCentral
32.
go back to reference Di Bonito P, Licenziati MR, Baroni MG et al (2014) High normal post-load plasma glucose, cardiometabolic risk factors and signs of organ damage in obese children. Obesity (Silver Spring) 22(8):1860–1864CrossRef Di Bonito P, Licenziati MR, Baroni MG et al (2014) High normal post-load plasma glucose, cardiometabolic risk factors and signs of organ damage in obese children. Obesity (Silver Spring) 22(8):1860–1864CrossRef
33.
go back to reference Weiss R, Otvos JD, Sinnreich R, Miserez AR, Kark JD (2011) The triglyceride to high-density lipoprotein-cholesterol ratio in adolescence and subsequent weight gain predict nuclear magnetic resonance-measured lipoprotein subclasses in adulthood. J Pediatr 158(1):44–50CrossRefPubMed Weiss R, Otvos JD, Sinnreich R, Miserez AR, Kark JD (2011) The triglyceride to high-density lipoprotein-cholesterol ratio in adolescence and subsequent weight gain predict nuclear magnetic resonance-measured lipoprotein subclasses in adulthood. J Pediatr 158(1):44–50CrossRefPubMed
34.
go back to reference Li WD, Fu KF, Li GM et al (2015) Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus. World J Gastroenterol 21(32):9607–9613CrossRefPubMedPubMedCentral Li WD, Fu KF, Li GM et al (2015) Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus. World J Gastroenterol 21(32):9607–9613CrossRefPubMedPubMedCentral
35.
go back to reference Pisto P, Santaniemi M, Bloigu R, Ukkola O, Kesäniemi Y (2014) Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study. BMJ Open 4(3):e004973CrossRefPubMedPubMedCentral Pisto P, Santaniemi M, Bloigu R, Ukkola O, Kesäniemi Y (2014) Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study. BMJ Open 4(3):e004973CrossRefPubMedPubMedCentral
36.
go back to reference Bonora E, Targher G, Alberiche M et al (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23(1):57–63CrossRefPubMed Bonora E, Targher G, Alberiche M et al (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23(1):57–63CrossRefPubMed
Metadata
Title
Impaired fasting glucose and impaired glucose tolerance in children and adolescents with overweight/obesity
Authors
P. Di Bonito
L. Pacifico
C. Chiesa
G. Valerio
E. Miraglia del Giudice
C. Maffeis
A. Morandi
C. Invitti
M. R. Licenziati
S. Loche
G. Tornese
F. Franco
M. Manco
M. G. Baroni
for the “CARdiometabolic risk factors in overweight and obese children in ITALY” (CARITALY) Study Group
Publication date
01-04-2017
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 4/2017
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-016-0576-8

Other articles of this Issue 4/2017

Journal of Endocrinological Investigation 4/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.